Search results for "slas europe 2018"
Selected Filters:
Key partnership increases access to organoid models
"Momentum is the conductor of a scientific instrument orchestra"
Enhancing quality in clinical laboratories with Six Sigma
Guest editorial by Mark Holland, Ph.D. Director, Bioinformatics/Biostatistics for Chemistry and Immunoassay Research and Development, Beckman Coulter
Tecan demonstrates how Veya supports digital and scalable automation at SLAS2025
Multiomics platform streamlines workflows and provides real-time insights, optimizing resource usage and ensuring smooth, data-driven operations
Making sense of IVDR for LC-MS
Agilent Microplates Reservoir Plates
Agilent TechnologiesAgilent offer polypropylene reservoirs for a wide range of automated liquid handlers and hand-held pipettors.
CNX Therapeutics and Adalvo announce strategic agreement for commercialization of Nitrofurantoin
This partnership grants CNX the exclusive rights to market Nitrofurantoin in 27 countries, including key markets such as the UK, France, Germany and Italy
Leqembi (lecanemab) is the first medicine that slows progression of early Alzheimer's disease to be authorized in the EU
For the treatment of adult patients with a clinical diagnosis of mild cognitive impairment and mild dementia due to Alzheimer's disease (early AD)
Valley Diagnostics and Sona Nanotech sign Heads of Terms agreement to advance commercialization of Bovine TB Assay
Agreement represents a significant step towards bringing Sona’s bTB rapid test to the market at scale
Optimizing SEM sample preparation with broad ion beam milling
Broad ion beam milling with Hitachi’s IM4000II & ArBlade 5000
The importance of high-quality cross-sectioning for battery research
Glox Therapeutics appoints new Chair and new scientific advisory board member
The expanded team will support growth and development, and the commercialization of precision antibiotics to help overcome antimicrobial resistance
Reflections on regulatory updates and industry recommendations for immunogenicity assessments: A CRO’s perspective
Deborah McManus and Gareth Satchell, Drug Development Solutions, LGC